Clinical response to neoadjuvant docetaxel predicts improved outcome in patients with large locally advanced breast cancer.

被引：0
|
作者：
Tham, YL [1 ]
Gutierrez, C [1 ]
Weiss, H [1 ]
Mohsin, S [1 ]
Hilsenbeck, S [1 ]
Elledge, R [1 ]
Chamness, G [1 ]
Osborne, CK [1 ]
Allred, DC [1 ]
Chang, JC [1 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：73S / 73S
页数：1
相关论文
共 50 条
  • [1] Clinical response to neoadjuvant docetaxel predicts improved outcome in patients with large locally advanced breast cancers
    Yee-Lu Tham
    L. Fernando Gomez
    Syed Mohsin
    M. Carolina Gutierrez
    Heidi Weiss
    Susan G. Hilsenbeck
    Richard M. Elledge
    Gary C. Chamness
    C. Kent Osborne
    D. Craig Allred
    Jenny C. Chang
    [J]. Breast Cancer Research and Treatment, 2005, 94 : 279 - 284
  • [2] Clinical response to neoadjuvant docetaxel predicts improved outcome in patients with large locally advanced breast cancers
    Tham, YL
    Gomez, LF
    Mohsin, S
    Gutierrez, MC
    Weiss, H
    Hilsenbeck, SG
    Elledge, RM
    Chamness, GC
    Osborne, CK
    Allred, DC
    Chang, JC
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 (03) : 279 - 284
  • [3] Response to Neoadjuvant Chemotherapy in Elderly Patients with Locally Advanced Breast Cancer.
    Vanderhaegen, J.
    Wildiers, H.
    Christiaens, M-R
    Smeets, A.
    Leunen, K.
    Neven, P.
    Vergote, I.
    Vanlimbergen, E.
    Weitens, C.
    Janssen, H.
    Moerman, P.
    Brouckaert, O.
    Brouwers, B.
    Paridaens, R.
    [J]. CANCER RESEARCH, 2011, 71
  • [4] Neoadjuvant Docetaxel in Locally Advanced Breast Cancer
    Andrew W. Hutcheon
    Steven D. Heys
    Tarun K. Sarkar
    [J]. Breast Cancer Research and Treatment, 2003, 79 (Suppl 1) : 19 - 24
  • [5] Neoadjuvant docetaxel in locally advanced breast cancer
    Hutcheon, AW
    Heys, SD
    Sarkar, TK
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2003, 79 : S19 - S24
  • [6] Clinical outcome and predictive factors for docetaxel and epirubicin neoadjuvant chemotherapy of locally advanced breast cancer
    Won, Hye Sung
    Kim, Yong Seok
    Kim, Jeong Soo
    Chang, Eun Deok
    Na, Sae Jung
    Whang, In Yong
    Lee, Dong Soo
    [J]. KOREAN JOURNAL OF INTERNAL MEDICINE, 2020, 35 (06): : 1489 - 1496
  • [7] Phase II trial of neoadjuvant docetaxel with or without bevacizumab in patients with locally advanced breast cancer.
    Overmoyer, B
    Silverman, P
    Leeming, R
    Shenk, R
    Lyons, J
    Ziats, N
    Jesberger, J
    Dumadag, L
    Remick, S
    Chen, H
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 58S - 58S
  • [8] Phase II trial of neoadjuvant docetaxel with or without bevacizumab in patients with locally advanced breast cancer.
    Overmoyer, B
    Silverman, P
    Leeming, R
    Shenk, R
    Lyons, J
    Jesberger, J
    Hartman, P
    Dumadag, L
    Chen, H
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S106 - S106
  • [9] Clinical and pathological response to neoadjuvant chemotherapy with different chemotherapy regimens predicts the outcome of locally advanced breast cancer
    Tang, Shicong
    Wang, Ke
    Zheng, Kai
    Liu, Jiadong
    Zhang, Hengyu
    Tan, Mingjian
    Li, Hongwan
    Li, Huimeng
    Tan, Xin
    Liu, Dequan
    Guo, Rong
    [J]. GLAND SURGERY, 2020, 9 (05) : 1415 - +
  • [10] miRNA profile predicts response to neoadjuvant chemotherapy in locally advanced breast cancer patients
    Sichieri, R. D.
    Silveira, W. A.
    Tirapelli, D. P. C.
    Oliveira, T. M. G.
    Mandarano, L. R. M.
    Muglia, V.
    Andrade, J. M.
    Tiezzi, D.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 : S199 - S199
12345